High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

Published:2012-06-14 Issue:1 Volume:7 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Fraunholz Ingeborg,Rödel Claus,Distel Luitpold,Rave-Fränk Marget,Kohler Daniela,Falk Stefan,Rödel Franz

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-7-88.pdf

Reference39 articles.

1. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3: 917-921. 10.1038/nm0897-917

2. Altieri DC: Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010, 430: 199-205. 10.1042/BJ20100814

3. Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008, 8: 61-70. 10.1038/nrc2293

4. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003, 3: 46-54. 10.1038/nrc968

5. Miura K, Fujibuchi W, Ishida K, Naitoh T, Ogawa H, Ando T, Yazaki N, Watanabe K, Haneda S, Shibata C, Sasaki I: Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer. Surg Today 2011, 41: 175-182. 10.1007/s00595-010-4390-1

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions;JCI Insight;2024-07-18

2. Prise en charge du cancer du canal anal en 2018;Oncologie;2018-10

3. Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC;BMC Cancer;2017-12

4. Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer;Frontiers in Immunology;2017-09-29

5. Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model;Nanomedicine: Nanotechnology, Biology and Medicine;2016-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3